BRNS: Barinthus Biotherapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
PEG koeffitsienti aktiv qiymatining kengayish sur'atlariga nisbatan dinamikasini ko'rsatadi, bunda 0.00 belgisi joriy holatni aks ettiradi. Barinthus Biotherapeutics (BRNS) onkologiya va viruslarga qarshi kurashish uchun zamonaviy hujayra terapiyasi usullarini ishlab chiqadi. Adenoviral vektor texnologiyasi barqaror talab fonida sezilarli bozor quvvatini ta'minlaydi. Biroq, ikkilamchi aksiyalar emissiyasi xavfi va so'nggi vaksina sinovlarining murakkabligi kapitalga bosim o'tkazmoqda.
Barinthus Bio (BRNS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Barinthus Biotherapeutics|BRNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Barinthus Biotherapeutics plc|BRNS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Barinthus Biotherapeutics Corp|BRNS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Barinthus Biotherapeutics|Tezkor likvidlik koeffitsiyenti barinthusbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
BRNS - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Barinthus Biotherapeutics|BRNS - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati barinthusbio.com|BRNS - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Barinthus Biotherapeutics plc|BRNS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Barinthus Biotherapeutics|BRNS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi barinthusbio.com|BRNS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Barinthus Biotherapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:BRNS - Barinthus Bio
PEG koeffitsiyenti kelajakdagi o'sish uchun haddan tashqari to'lov miqdorini aniqlash uchun P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi. Investorlar yuqori salohiyatga ega bo'lgan past baholangan aktivlarni aniqlash uchun GURU.Markets platformasidagi joriy P/E-o'sish koeffitsiyentidan foydalanadilar. Birga solishtirganda pastroq qiymat investitsiya jozibadorligini tasdiqlaydi. Bu Barinthus Biotherapeutics (BRNS) uchun juda muhimdir, chunki vaksinalarni kengaytirish qimmat turadigan sinovlardan so'ng daromadning keskin o'sishini ta'minlaydi.
Raqobatdosh kompaniyalar
ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Aclaris Therapeutics Inc.|Kyverna (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|PEG multiplikatori Avalo Therapeutics Inc. (AVTX)|PEG multiplikatori ELDN (eledon.com)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA (Zura Bio Limited) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Adagene (ADAG) - PEG multiplikatori|IMA (ikenaoncology.com) - PEG multiplikatori|shattucklabs.com (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Equillium Inc (EQ)|Connect Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunic, Inc. IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR: Narxning foydaga va o‘sish sur’atiga nisbati|ACET: PEG multiplikatori|Celularity Corp (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|geovax.com - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (Edesa Biotech Inc)|IBIO: PEG multiplikatori|Carisma Tx (CARM) - PEG multiplikatori|XTLB (XTL Biopharmaceuticals) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics, Inc.)|PEG multiplikatori Aptevo (APVO)|PEG multiplikatori AIM (aimimmuno.com)|PEG multiplikatori Aditxt Corp ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Revelation Bio (REVB) - PEG multiplikatori|INDP (Indaptus Corp) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori
